|
advertisement
|
Company Overview: |
| Cephalon, a biopharmaceutical company, specializes in drugs to treat and manage neurological diseases, sleep disorders, cancer and pain. |
Products and Services: |
| Cephalon currently markets more than 20 products internationally, including three proprietary products (PROVIGIL, ACTIQ, GABITRIL) in the United States. The companyalso develops and manufactures orally disintegrating tablets using proprietary technologies through its wholly-owned subsidiary, CIMA LABS INC. |
Key Personnel Facts: |
| Cephalon employs more than 2,300 people worldwide with operations in the United States and Europe. |
Key Financial Facts: |
| Cephalon had a total revenue of 1,015 million USD in 2004. |
Back to Top
|
|
Working @ Cephalon Inc.
Have your shout about working or interveiwing at Cephalon Inc.
1 message posted
Message Posted:
Working @ Cephalon
Have your say about working, interviewing or applying for a job at ...
Author: Obi Posted: 10/10/2005 7:49:07 AM |
View or add comments about Cephalon Inc.
Back to Top
|
Cephalon Inc. in the News
- ::: Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
Published: Monday, December 04, 2006
- Barr Announces Agreements with Cephalon, Inc. Regarding Settlement of ACTIQ(R) and PROVIGIL(R) Patent Litigati
Published: Thursday, February 02, 2006
- Barr Announces Agreements with Cephalon, Inc. Regarding
Published: Thursday, February 02, 2006
- Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. Regarding Settlement of PROVIGIL(R) and ACTIQ(R) Patent Litigations
Published: Thursday, February 02, 2006
- Barr Announces Agreements with Cephalon, Inc. Regarding Settlement of ACTIQ(R) and PROVIGIL(R) Patent Litigati
Published: Thursday, February 02, 2006
View more news about Cephalon Inc.
Back To Top |
|
|
|
|
Categories:
|
Biotechnology
|
|
Back to Top
|
|
|
|